Farrell Peter C
FARRELL PETER C, DIR, reported an open-market or private sale at RESMED INC involving 970.000000 shares for an estimated $227688.10. Reported holdings after the transaction were 51803.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 02, 2026
- Filing date
- Sep 04, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 52,773 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RMD price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0000943819-26-000050 ResMed Common Stock
- Transaction date
- Sep 02, 2026 Filed Sep 04, 2026, 10:30 AM · 2d delay
- Shares
- 970 sh $234.73 per share
- Estimated value
- -$227k Computed from shares × price
- Holdings after
- 51,803 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
0 other transactions
0 recent txs